PDF herunterladen
CC BY-NC-ND 4.0 · Revista Urología Colombiana / Colombian Urology Journal 2019; 28(02): 142-148
DOI: 10.1055/s-0038-1670646
Review Articles | Artículos de Revisión
Sociedad Colombiana de Urología. Publicado por Thieme Revinter Publicações Ltda Rio de Janeiro, Brazil

An Update in the Use of JJ Stents

Artikel in mehreren Sprachen: English | español
Ana María Ortiz Zableh
1   Semillero de investigación en urología y genética, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Danielle Bastidas Rosas
2   Estudiante de medicina, Semillero de investigación en urología y genética, Pontificia Universidad Javeriana, Bogotá, Colombia
,
Hugo López Ramos
3   Urológo, Hospital Universitario San Ignacio, Bogotá, Colombia
› Institutsangaben
Weitere Informationen

Publikationsverlauf

05. Mai 2018

11. Juni 2018

Publikationsdatum:
01. Oktober 2018 (online)

   Lizenzen und Reprints

Abstract

Introduction Ureteral stents are widely used tools in the daily practice of the urologist due to the fact that they solve the endo- and extraluminal ureteral obstructions, enabling an adequate urine flow. They are the preferred tool because they are easy to insert and versatile, and are used to treat various urologic pathologies; nonetheless, they are not exempt from complications.

Objectives To present an update in the use of JJ stents, describing their main associated symptoms and complications, indications and newest developments.

Materials and Methods We performed a literature review in the Embase, Pubmed and Google Scholar databases, with the following terms and cross-references: ureteral stent; diagnosis; treatment; and urology, restricting the search to the past 7 years. A total of 428 articles were found, and 49 were used in the revision.

Results We described the symptoms and complications associated with the use of JJ stents and their prevention, their use in the treatment of lithiasis and oncologic diseases, the utility of metallic stents, and new designs and improvements in their development.

Conclusions JJ stents remain a very useful tool in the daily practice of the urologist, but are not exempt from having adverse effects and complications. There have been advances that decrease the adverse effects associated with their use, mainly infection, symptoms associated to the insertion, and risk of incrustation.

Keywords

catheters - ureteral stent - infection - ureteral obstruction - vesico-ureteral reflux - urolithiasis
 

  • References

  • 1 Tailly T, Denstedt J. Fundamentals of Urinary Tract Drainage. In: Wein, Alan J. MD, PhD (HON), FACS; Kavoussi, Louis R. MD, MBA; Partin, Alan W. MD, PhD; Peters, Craig AM. , ed. Campbell's Urology. 11th ed. Philadelphia: Elsevier; 2016: 1119-1135
    Google Scholar
  • 2 Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley Jr FX, Timoney AG. Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 2003; 169 (03) 1060-1064 Doi: 10.1097/01.ju.0000049198.53424.1d
    CrossrefPubMedGoogle Scholar
  • 3 Scarneciu I, Lupu S, Pricop C, Scarneciu C. Morbidity and impact on quality of life in patients with indwelling ureteral stents: A 10-year clinical experience. Pak J Med Sci 2015; 31 (03) 522-526 Doi: 10.12669/pjms.313.6759
    PubMedGoogle Scholar
  • 4 Sivalingam S, Monga M. Management of Ureteral Stent Discomfort in Contemporary Urology Practice. Urol Pract 2014; 1 (03) 141-145 Doi: 10.1016/j.urpr.2014.06.001
    PubMedGoogle Scholar
  • 5 Soria F, Morcillo E, Serrano A. , et al. Preliminary Assessment of a New Antireflux Ureteral Stent Design in Swine Model. Urology 2015; 86 (02) 417-422 Doi: 10.1016/j.urology.2015.05.020
    CrossrefPubMedGoogle Scholar
  • 6 Alfredo ML. Catéter ureteral olvidado. Urol Colomb 2007; 16: 139-148
    PubMedGoogle Scholar
  • 7 Kwon JK, Cho KS, Oh CK. , et al. The beneficial effect of alpha-blockers for ureteral stent-related discomfort: systematic review and network meta-analysis for alfuzosin versus tamsulosin versus placebo. BMC Urol 2015; 15: 55 Doi: 10.1186/s12894-015-0050-5
    CrossrefPubMedGoogle Scholar
  • 8 He F, Man LB, Li GZ, Liu N. Efficacy of α-blocker in improving ureteral stent-related symptoms: a meta-analysis of both direct and indirect comparison. Drug Des Devel Ther 2016; 10: 1783-1793 Doi: 10.2147/DDDT.S103195
    PubMedGoogle Scholar
  • 9 Kuyumcuoglu U, Eryildirim B, Tuncer M, Faydaci G, Tarhan F, Ozgül A. Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J 2012; 6 (06) E234-E237 Doi: 10.5489/cuaj.10143
    CrossrefPubMedGoogle Scholar
  • 10 Lee FC, Holt SK, Hsi RS, Haynes B, Harper JD. Preoperative Belladonna and Opium Suppository for Ureteral Stent Pain: a Randomized, Double-Blinded, Placebo Controlled Study. Urology 2017; 100: 27-32
    CrossrefPubMedGoogle Scholar
  • 11 Abt D, Mordasini L, Warzinek E. , et al. Is intravesical stent position a predictor of associated morbidity?. Korean J Urol 2015; 56 (05) 370-378 Doi: 10.4111/kju.2015.56.5.370
    CrossrefPubMedGoogle Scholar
  • 12 Mendez-Probst CE, Goneau LW, MacDonald KW. , et al. The use of triclosan eluting stents effectively reduces ureteral stent symptoms: a prospective randomized trial. BJU Int 2012; 110 (05) 749-754 Doi: 10.1111/j.1464-410X.2011.10903.x
    CrossrefPubMedGoogle Scholar
  • 13 Abt D, Warzinek E, Schmid HP, Haile SR, Engeler DS. Influence of patient education on morbidity caused by ureteral stents. Int J Urol 2015; 22 (07) 679-683 Doi: 10.1111/iju.12782
    CrossrefPubMedGoogle Scholar
  • 14 García-Aparicio L, Blázquez-Gómez E, Martin O, Krauel L, De Haro I, Rodó J. Bacterial characteristics and clinical significance of ureteral double-J stents in children. Actas Urol Esp 2015; 39 (01) 53-56 Doi: 10.1016/j.acuro.2014.04.008
    CrossrefPubMedGoogle Scholar
  • 15 Hashimoto J, Takahashi S, Kurimura Y, Takeyama K, Kunishima Y, Tsukamoto T. Clinical relevance of single administration of prophylactic antimicrobial agents against febrile events after removal of ureteral stents for patients with urinary diversion or reconstruction. Int J Urol 2010; 17 (02) 163-166 Doi: 10.1111/j.1442-2042.2009.02432.x
    CrossrefPubMedGoogle Scholar
  • 16 Nevo A, Mano R, Schreter E, Lifshitz DA. Clinical implications of stent culture in patients with indwelling ureteral stents prior to ureteroscopy. J Urol 2017; 198 (01) 116-121 Doi: 10.1016/j.juro.2017.01.064
    CrossrefPubMedGoogle Scholar
  • 17 Keheila M, Chan C, Cheriyan S. , et al. Increasing Fungal Colonization With Increased Duration of Ureteral Stents. J Urol 2016; 195 (04) e1077 Doi: 10.1016/j.juro.2016.02.2153
    CrossrefPubMedGoogle Scholar
  • 18 Cirioni O, Ghiselli R, Silvestri C. , et al. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection. J Antimicrob Chemother 2011; 66 (06) 1318-1323 Doi: 10.1093/jac/dkr107
    CrossrefPubMedGoogle Scholar
  • 19 Kawahara T, Miyamoto H, Ito H. , et al. Discolored ureteral stents: findings in urinalysis and urine culture. PLoS One 2015; 10 (04) e0122984 Doi: 10.1371/journal.pone.0122984
    CrossrefPubMedGoogle Scholar
  • 20 Ahallal Y, Khallouk A, El Fassi MJ, Farih MH. Risk factor analysis and management of ureteral double-j stent complications. Rev Urol 2010; 12 (2-3): e147-e151 Doi: 10.3909/riu0447
    PubMedGoogle Scholar
  • 21 el-Faqih SR, Shamsuddin AB, Chakrabarti A. , et al. Polyurethane internal ureteral stents in treatment of stone patients: morbidity related to indwelling times. J Urol 1991; 146 (06) 1487-1491
    CrossrefPubMedGoogle Scholar
  • 22 Adanur S, Ozkaya F. Challenges in treatment and diagnosis of forgotten/encrusted double-J ureteral stents: the largest single-center experience. Ren Fail 2016; 38 (06) 920-926 Doi: 10.3109/0886022X.2016.1172928
    CrossrefPubMedGoogle Scholar
  • 23 Arenas JL, Shen JK, Keheila M. , et al. Kidney, Ureter, and Bladder (KUB): A Novel Grading System for Encrusted Ureteral Stents. Urology 2016; 97: 51-55 Doi: 10.1016/j.urology.2016.06.050
    CrossrefPubMedGoogle Scholar
  • 24 Althaus AB, Li K, Pattison E, Eisner B, Pais V, Steinberg P. Rate of dislodgment of ureteral stents when using an extraction string after endoscopic urological surgery. J Urol 2015; 193 (06) 2011-2014 Doi: 10.1016/j.juro.2014.12.087
    CrossrefPubMedGoogle Scholar
  • 25 Molina WR, Donalisio da Silva R, Kenny MC. , et al. Mp08-14 Stentracker: a Smartphone Application for the Prevention of “Forgotten” Retained Ureteral Stents (Rus). J Urol 2016; 195 (04) e90 Doi: 10.1016/j.juro.2016.02.2259
    PubMedGoogle Scholar
  • 26 Dakkak Y, Janane A, Ould-Ismail T, Ghadouane M, Ameur A, Abbar M. Management of encrusted ureteral stents. Afr J Urol 2012; 18 (03) 131-134 Doi: 10.1016/j.afju.2012.08.013
    CrossrefPubMedGoogle Scholar
  • 27 Pais Jr VM, Smith RE, Stedina EA, Rissman CM. Does Omission of Ureteral Stents Increase Risk of Unplanned Return Visit? A Systematic Review and Meta-Analysis. J Urol 2016; 196 (05) 1458-1466 Doi: 10.1016/j.juro.2016.05.109
    CrossrefPubMedGoogle Scholar
  • 28 Larkin S, Preston D. Where are the Stents? A Computerized Tracking System to Eliminate the Forgotten Ureteral Stent. Urol Pract 2015; 2 (03) 106-108 Doi: 10.1016/j.urpr.2014.09.010
    PubMedGoogle Scholar
  • 29 Baumgarten AC, Rydberg MG, Bates JN, Teigland CM, Roy OP. Reducing the Incidence of Retained Double-J Ureteral Stents: A Multidisciplinary Approach. Urol Pract 2016; 3 (05) 325-331 Doi: 10.1016/j.urpr.2015.10.005
    PubMedGoogle Scholar
  • 30 Pengfei S, Yutao L, Jie Y. , et al. The results of ureteral stenting after ureteroscopic lithotripsy for ureteral calculi: a systematic review and meta-analysis. J Urol 2011; 186 (05) 1904-1909 Doi: 10.1016/j.juro.2011.06.066
    CrossrefPubMedGoogle Scholar
  • 31 Wang H, Man L, Li G, Huang G, Liu N, Wang J. Meta-Analysis of Stenting versus Non-Stenting for the Treatment of Ureteral Stones. PLoS One 2017; 12 (01) e0167670 Doi: 10.1371/journal.pone.0167670
    CrossrefPubMedGoogle Scholar
  • 32 Picozzi SCM, Ricci C, Stubinski R. , et al. Is stone diameter a variable in the decision process of employing a ureteral stent in patients undergoing uncomplicated ureterorenoscopy and associated intracorporeal lithotripsy?. World J Urol 2013; 31 (06) 1617-1625 Doi: 10.1007/s00345-013-1046-y
    CrossrefPubMedGoogle Scholar
  • 33 You JH, Kim YG, Kim MK. Should we place ureteral stents in retroperitoneal laparoscopic ureterolithotomy?: Consideration of surgical techniques and complications. Korean J Urol 2014; 55 (08) 511-514 Doi: 10.4111/kju.2014.55.8.511
    CrossrefPubMedGoogle Scholar
  • 34 Chow PM, Chiang IN, Chen CY. , et al. Malignant ureteral obstruction: Functional duration of metallic versus polymeric ureteral stents. PLoS One 2015; 10 (08) e0135566 Doi: 10.1371/journal.pone.0135566
    CrossrefPubMedGoogle Scholar
  • 35 Goldsmith ZG, Wang AJ, Bañez LL. , et al. Outcomes of metallic stents for malignant ureteral obstruction. J Urol 2012; 188 (03) 851-855 Doi: 10.1016/j.juro.2012.04.113
    CrossrefPubMedGoogle Scholar
  • 36 Chow PM, Hsu JS, Wang SM, Yu HJ, Pu YS, Liu KL. Metallic ureteral stents in malignant ureteral obstruction: short-term results and radiological features predicting stent failure in patients with non-urological malignancies. World J Urol 2014; 32 (03) 729-736 Doi: 10.1007/s00345-013-1143-y
    CrossrefPubMedGoogle Scholar
  • 37 Wang JY, Zhang HL, Zhu Y, Qin XJ, Dai BO, Ye DW. Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients. Oncol Lett 2016; 11 (01) 879-883 Doi: 10.3892/ol.2015.3961
    CrossrefPubMedGoogle Scholar
  • 38 Kamiyama Y, Matsuura S, Kato M. , et al. Stent failure in the management of malignant extrinsic ureteral obstruction: risk factors. Int J Urol 2011; 18 (05) 379-382 Doi: 10.1111/j.1442-2042.2011.02731.x
    CrossrefPubMedGoogle Scholar
  • 39 Elsamra SE, Leavitt DA, Motato HA. , et al. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents. Int J Urol 2015; 22 (07) 629-636 Doi: 10.1111/iju.12795
    CrossrefPubMedGoogle Scholar
  • 40 Chung HH, Kim MD, Won JY. , et al. Multicenter experience of the newly designed covered metallic ureteral stent for malignant ureteral occlusion: comparison with double J stent insertion. Cardiovasc Intervent Radiol 2014; 37 (02) 463-470 Doi: 10.1007/s00270-013-0675-2
    CrossrefPubMedGoogle Scholar
  • 41 Wang HJ, Lee TY, Luo HL. , et al. Application of resonance metallic stents for ureteral obstruction. BJU Int 2011; 108 (03) 428-432 Doi: 10.1111/j.1464-410X.2010.09842.x
    CrossrefPubMedGoogle Scholar
  • 42 Kadlec AO, Ellimoottil CS, Greco KA, Turk TM. Five-year experience with metallic stents for chronic ureteral obstruction. J Urol 2013; 190 (03) 937-941 Doi: 10.1016/j.juro.2013.02.070
    CrossrefPubMedGoogle Scholar
  • 43 Kim KH, Cho KS, Ham WS, Hong SJ, Han KS. Early Application of Permanent Metallic Mesh Stent in Substitution for Temporary Polymeric Ureteral Stent Reduces Unnecessary Ureteral Procedures in Patients With Malignant Ureteral Obstruction. Urology 2015; 86 (03) 459-464 Doi: 10.1016/j.urology.2015.06.021
    CrossrefPubMedGoogle Scholar
  • 44 Kallidonis PS, Georgiopoulos IS, Kyriazis ID, Kontogiannis S, Al-Aown AM, Liatsikos EN. The full metallic double-pigtail ureteral stent: Review of the clinical outcome and current status. Indian J Urol 2015; 31 (01) 8-14 Doi: 10.4103/0970-1591.134232
    CrossrefPubMedGoogle Scholar
  • 45 Kadlec AO, Ellimoottil CS, Greco KA, Turk TM. Five-year experience with metallic stents for chronic ureteral obstruction. J Urol 2013; 190 (03) 937-941 Doi: 10.1016/j.juro.2013.02.070
    CrossrefPubMedGoogle Scholar
  • 46 Lee JN, Kim BS. Comparison of efficacy and bladder irritation symptoms among three different ureteral stents: a double-blind, prospective, randomized controlled trial. Scand J Urol 2015; 49 (03) 237-241 Doi: 10.3109/21681805.2014.981205
    PubMedGoogle Scholar
  • 47 Huynh D, Hockman L, Trulson J, Wakefield M. Advantages and Technical Challenges of Lighted Ureteral Stents During Laparoscopic Bowel Surgery. J Urol 2015; 193 (04) e474 Doi: 10.1016/j.juro.2015.02.1437
    PubMedGoogle Scholar
  • 48 Soria F, Morcillo E, Serrano A. , et al. Preliminary Assessment of a New Antireflux Ureteral Stent Design in Swine Model. Urology 2015; 86 (02) 417-422 Doi: 10.1016/j.urology.2015.05.020
    CrossrefPubMedGoogle Scholar
  • 49 Li G, Wang ZX, Fu WJ. , et al. Introduction to biodegradable polylactic acid ureteral stent application for treatment of ureteral war injury. BJU Int 2011; 108 (06) 901-906 Doi: 10.1111/j.1464-410X.2010.09992.x
    PubMedGoogle Scholar
  • 50 Barros AA, Oliveira C, Lima E, Duarte ARC, Reis RL. Gelatin-based biodegradable ureteral stents with enhanced mechanical properties. Appl Mater Today 2016; 5: 9-18 Doi: 10.1016/j.apmt.2016.07.006
    PubMedGoogle Scholar
  • 51 Barros AA, Browne S, Oliveira C. , et al. Drug-eluting biodegradable ureteral stent: New approach for urothelial tumors of upper urinary tract cancer. Int J Pharm 2016; 513 (1-2): 227-237 Doi: 10.1016/j.ijpharm.2016.08.061
    CrossrefPubMedGoogle Scholar
  • 52 Rosman BM, Barbosa JA, Cendron M, Retik AB, Nguyen HT, Cilento BG. 862 Development and Evaluation of a Novel Gel-Based Ureteral Stent With Biofilm Resistant Characteristics. J Urol 2012; 187 (04) e352 Doi: 10.1016/j.juro.2012.02.955
    CrossrefPubMedGoogle Scholar